Metastasis From Malignant Tumor of Cervix clinical trials at UCSF
1 research study open to eligible people
When cancer spreads from the cervix to other places, it is called metastasis. UCSF is running clinical trials that use radiation and a new type of drug. These studies are to see how effective this treatment is for people with advanced cancer.
Showing trials for
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
open to eligible people ages 18 years and up
The 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy.
San Francisco, California and other locations
Last updated: